Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$134,293,434
-$12,581,033 QoQ
Shares Held
708,224
-4.9% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
2.26%
of 13F equity value
Holder Rank
#111
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $569,205,568 across 10 Drug Manufacturers - General names. AZN ranks #2 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
818,972 | $206,086,114 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
708,224 | $134,293,434 | |
| 3 | JNJ |
Johnson & Johnson
|
468,190 | $118,906,214 | |
| 4 | PFE |
Pfizer Inc
|
1,735,218 | $41,784,049 | |
| 5 | GSK |
GSK plc
|
634,985 | $33,285,913 | |
| 6 | MRK |
Merck & Co., Inc.
|
144,979 | $18,629,801 | |
| 7 | LLY |
ELI LILLY & Co
|
8,977 | $10,767,284 | |
| 8 | AMGN |
Amgen Inc
|
7,793 | $2,822,001 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134,293,434 | 708,224 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $146,874,467 | 744,724 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||